Diffusion-weighted and multiphase contrast-enhanced MRI as surrogate markers of response to neoadjuvant sunitinib in metastatic renal cell carcinoma

BACKGROUND: Current imaging criteria for categorising disease response in metastatic renal cell carcinoma (mRCC) correlate poorly with overall survival (OS) in patients on anti-angiogenic therapies. We prospectively assess diffusion-weighted and multiphase contrast-enhanced (MCE) MR imaging (MRI) as...

Descripción completa

Detalles Bibliográficos
Autores principales: Bharwani, N, Miquel, M E, Powles, T, Dilks, P, Shawyer, A, Sahdev, A, Wilson, P D, Chowdhury, S, Berney, D M, Rockall, A G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915138/
https://www.ncbi.nlm.nih.gov/pubmed/24366299
http://dx.doi.org/10.1038/bjc.2013.790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915138/
https://www.ncbi.nlm.nih.gov/pubmed/24366299
http://dx.doi.org/10.1038/bjc.2013.790

Ejemplares similares